{"id":"CHEMBL108766","canonicalSmiles":"CCCCCCCCCCCC(=O)O","inchiKey":"POULHZVOKOAJMA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DODECANOATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dodecanoic Acid","Dodecanoic Acid Anion","Lauric Acid"],"crossReferences":{"PubChem":["144209347","144213327","17388953","17389665","56462800"],"Wikipedia":["Lauric_acid"],"drugbank":["DB03017"],"chEBI":["30805"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL111077","canonicalSmiles":"CCCCCCCCCCCCCC(=O)O","inchiKey":"TUNFSRHWOTWDNC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MYRISTIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FEMA NO. 2764","Myristic acid","N-tetradecan-1-oic acid","N-tetradecanoic acid","NSC-5028","PHILACID-1400","PRIFRAC-2942"],"crossReferences":{"PubChem":["144209050","144213098","17389652","26752895","56436661"],"Wikipedia":["Myristic_acid"],"drugbank":["DB08231"],"chEBI":["28875"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1113","canonicalSmiles":"Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2","inchiKey":"QWGDMFLQWFTERH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"AMOXAPINE","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amoxapine","Asendin","Asendis","Defanyl"],"synonyms":["Amoxapine","CL 67,772","CL 67772","CL-67,772","CL-67772","NSC-759559"],"crossReferences":{"DailyMed":["amoxapine"],"PubChem":["104171096","11110675","11110676","124879022","124879024","144203615","144212669","170465376","26747067","26751577","50100159","50104205","50104206","85230879","855963","90341240"],"Wikipedia":["Amoxapine"],"drugbank":["DB00543"],"chEBI":["2675"]},"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546","ENSG00000184845","ENSG00000069696","ENSG00000149295","ENSG00000151577","ENSG00000169676"],"count":7},"linkedDiseases":{"rows":["EFO_0003761"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1980 and is indicated for unipolar depression. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1160559","canonicalSmiles":"O=C(O)c1ccc2ccccc2n1","inchiKey":"LOAUVZALPPNFOQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUINALDIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Quinoline-2-Carboxylic Acid","Quinoline-2-Carboxylic Acid Anion"],"crossReferences":{"drugbank":["DB02428"],"chEBI":["18386"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL117","canonicalSmiles":"O=c1cc(-c2ccccc2)oc2cc(O)cc(O)c12","inchiKey":"RTIXKCRFFJGDFG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHRYSIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-407436"],"crossReferences":{"PubChem":["11112354","124882275","124882277","124882278","124882279","144212652","174006352","26748373","26748375","26753723","26753724","46501295","477194","49674567"],"Wikipedia":["Chrysin"],"drugbank":["DB15581"],"chEBI":["75095"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1182247","canonicalSmiles":"CCCCCCCCCC[N+](C)(C)CCCCCCCCCC","inchiKey":"JGFDZZLUDWMUQH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIDECYLDIMETHYLAMMONIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["29217824"],"drugbank":["DB04221"]},"childChemblIds":["CHEMBL224987","CHEMBL2358929"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200454","canonicalSmiles":"CC(C)[C@H](N)C(=O)OCC(CO)OCn1cnc2c(=O)nc(N)[nH]c21.Cl","inchiKey":"ZORWARFPXPVJLW-MTFPJWTKSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VALGANCICLOVIR HYDROCHLORIDE","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201314","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Valcyte","Valganciclovir hydrochloride"],"synonyms":["NSC-760349","RO107-9070/194","RS-079070-194","RS-79070-194","Valganciclovir hcl","Valganciclovir hydrochloride"],"crossReferences":{"DailyMed":["valganciclovir%20hydrochloride"],"PubChem":["144206193"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 3 approved and 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200678","canonicalSmiles":"COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C.O=S(=O)(O)O","inchiKey":"DQSGVVGOPRWTKI-QVFAWCHISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATAZANAVIR SULFATE","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1163","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Atazanavir sulfate","Reyataz"],"synonyms":["Atazanavir so4","Atazanavir sulfate","Atazanavir sulphate","Atazanaviri sulfas","Atazor","BMS-232632-05","NSC-742546"],"crossReferences":{"DailyMed":["atazanavir%20sulfate"],"chEBI":["31243"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and has 3 approved indications."}
{"id":"CHEMBL1200709","canonicalSmiles":"C/C=C/C(=O)N(CC)c1ccccc1C","inchiKey":"DNTGGZPQPQTDQF-XBXARRHUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CROTAMITON","yearOfFirstApproval":1949,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Crotan","Eurax"],"synonyms":["Crotamiton","N-ethyl-o-crotonotoluidide","N-ethylcrotono-o-toluidide","NSC-758951"],"crossReferences":{"DailyMed":["crotamiton"],"PubChem":["26719689","26747823","85148369"],"Wikipedia":["Crotamiton"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1949."}
{"id":"CHEMBL1200891","canonicalSmiles":"CN1CCCN=C1COC(=O)C(O)(c1ccccc1)C1CCCCC1.Cl","inchiKey":"WXAYTPABEADAAB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYPHENCYCLIMINE HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1495","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Daricon"],"synonyms":["NSC-528449","Oxiphencyclimine chloride","Oxyphencyclimine hcl","Oxyphencyclimine hydrochloride"],"crossReferences":{"PubChem":["144204969","170465276","26748867","56422213","855685"],"Wikipedia":["Oxyphencyclimine"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201174","canonicalSmiles":"N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F.O.O=P(O)(O)O","inchiKey":"GQPYTJVDPQTBQC-KLQYNRQASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SITAGLIPTIN PHOSPHATE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1422","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Janumet Xr","Januvia"],"synonyms":["Glactiv","MK-0431","MK0431","ONO-5435","Sitagliptin monophosphate","Sitagliptin monophosphate anhydrous","Sitagliptin monophosphate monohydrate","Sitagliptin phosphate","Sitagliptin phosphate anhydrous","Sitagliptin phosphate hydrate","Sitagliptin phosphate monohydrate"],"crossReferences":{"DailyMed":["sitagliptin%20phosphate"]},"linkedTargets":{"rows":["ENSG00000197635"],"count":1},"linkedDiseases":{"rows":["HP_0000083","MONDO_0021187","EFO_0000712","EFO_0000612","HP_0001943","MONDO_0005148","EFO_0000400"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 4 approved and 2 investigational indications."}
{"id":"CHEMBL1201207","canonicalSmiles":"C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)(O)O","inchiKey":"VQODGRNSFPNSQE-DVTGEIKXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETAMETHASONE PHOSPHORIC ACID","yearOfFirstApproval":1965,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Betamethasone phosphate","Betamethasone phosphoric acid"],"crossReferences":{"DailyMed":["betamethasone%20sodium%20phosphate"],"drugbank":["DB14669"],"chEBI":["68603"]},"childChemblIds":["CHEMBL1200762"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","HP_0030838","EFO_1000906","EFO_0001356","HP_0003418","HP_0001742","HP_0004798","EFO_1001909","EFO_0002950","EFO_1001097","HP_0006536","HP_0030833","EFO_0000676","EFO_0004616","HP_0003419","EFO_0009552","MONDO_0005178","EFO_0005752","EFO_1001434"],"count":19},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1965 and has 5 approved and 7 investigational indications."}
{"id":"CHEMBL1201225","canonicalSmiles":"II","inchiKey":"PNDPGZBMCMUPRI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IODINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Iodine","Iodine mild","Iodine strong","Iodium","Iodum","Jodosan","NSC-42355","Tegodyne"],"crossReferences":{"PubChem":["144211611"],"drugbank":["DB05382"],"chEBI":["17606"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL1201531","drugType":"Small molecule","blackBoxWarning":false,"name":"VERATRUM VIRIDE ROOT","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vertavis"],"synonyms":["American hellebore root","American white hellebore root","Green false hellebore root","Green veratrum","Indian poke root","Veratrum","Veratrum alkaloids","Veratrum eschscholtzianum root","Veratrum eschscholtzii root","Veratrum viride","Veratrum viride root"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for hypertension."}
{"id":"CHEMBL1201570","drugType":"Protein","blackBoxWarning":false,"name":"ANAKINRA","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Antril","Kineret"],"synonyms":["AMG-719","Alta-2530","Alta2530","Anakinra","Interleukin-1 receptor antagonist anakinra","Osp-101"],"crossReferences":{"DailyMed":["anakinra"],"DrugCentral":["5017"],"Wikipedia":["Anakinra"]},"linkedTargets":{"rows":["ENSG00000115594"],"count":1},"linkedDiseases":{"rows":["EFO_0001361","EFO_1000710","EFO_0011057","EFO_0007323","EFO_0004274","EFO_1000657","EFO_0005669","EFO_0009536","EFO_0010638","EFO_1001345","EFO_0000540","EFO_0007135","EFO_0000096","EFO_0000544","EFO_0003884","MONDO_0004976","EFO_0000400","Orphanet_379","EFO_0002618","MONDO_0005149","EFO_0009672","EFO_1001806","EFO_0000660","MONDO_0008315","HP_0100806","EFO_1001209","EFO_1001231","MONDO_0100096","EFO_0000398","MONDO_0004979","EFO_0007328","HP_0001943","EFO_0001378","EFO_0003073","MONDO_0007254","EFO_0004246","EFO_1001480","EFO_1000044","EFO_0009507","Orphanet_1451","EFO_0003144","Orphanet_47045","EFO_0007427","EFO_0004238","Orphanet_342","EFO_0009609","Orphanet_797","EFO_0000616","EFO_0000694","EFO_0000685","EFO_0003843","EFO_0002609","EFO_0003106","EFO_0000195","MONDO_0005301","EFO_1001999","EFO_0000095","MONDO_0005147","EFO_0000764","EFO_0008583","MONDO_0043510","MONDO_0024880","MONDO_0005178","EFO_0004540"],"count":64},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 4 approved and 50 investigational indications."}
{"id":"CHEMBL1201586","drugType":"Antibody","blackBoxWarning":false,"name":"PALIVIZUMAB","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Synagis","Synagis abbosynagis"],"synonyms":["MEDI-493","Palivizumab"],"crossReferences":{"DailyMed":["palivizumab"],"DrugCentral":["4935"],"Wikipedia":["Palivizumab"]},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and is indicated for respiratory system disease and bronchopulmonary dysplasia and has 2 investigational indications."}
{"id":"CHEMBL1201770","canonicalSmiles":"C[N+]1(CC2CC2)CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5.[Br-]","inchiKey":"IFGIYSGOEZJNBE-KNLJMPJLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLNALTREXONE BROMIDE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1186579","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Relistor"],"synonyms":["MRZ 2663BR","MRZ-2663BR","Methylnaltrexone bromide","Moa-728","N-methylnaltrexone bromide","Naltrexone methobromide","Naltrexone methylbromide"],"crossReferences":{"DailyMed":["methylnaltrexone%20bromide"]},"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_0008585","MONDO_0004567","HP_0002019"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and is indicated for constipation and has 2 investigational indications."}
{"id":"CHEMBL1209734","canonicalSmiles":"COc1nc(N)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(N[C@@H](C)C(=O)OCC(C)(C)C)Oc2cccc3ccccc23)[C@@H](O)[C@@]1(C)O","inchiKey":"YFXGICNMLCGLHJ-RSKRLRQZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-986094","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-986094","Bms-986094","INX 08189","INX-08189","INX-089","INX-189","Inx-08189"],"crossReferences":{"drugbank":["DB11966"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1222398","canonicalSmiles":"N[C@H](CO)Cc1c[nH]c2ccccc12","inchiKey":"UDQCRUSSQAXPJY-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRYPTOPHANOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04236"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230308","canonicalSmiles":"CC(C)CCC(=O)O","inchiKey":"FGKJLKRYENPLQH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230308","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03993"],"chEBI":["74903"]},"childChemblIds":["CHEMBL1762644"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230421","canonicalSmiles":"Cc1cn([C@@H]2O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]2O)c(=O)[nH]c1=O","inchiKey":"IGWHDMPTQKSDTL-JXOAFFINSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230421","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04243"],"chEBI":["77120"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230671","canonicalSmiles":"O=c1[nH]cnc2cc[nH]c12","inchiKey":"UWMXUDUWVFWJPX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"9-Deazahypoxanthine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["9-Deazahypoxanthine"],"crossReferences":{"drugbank":["DB04095"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231012","canonicalSmiles":"N=C(N)c1ccc(CC(=O)C(=O)O)cc1","inchiKey":"ZXBYWYQEQQBMBT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231012","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02018"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233506","canonicalSmiles":"CCCCCc1ccc(C(=O)Nc2ccc(S(=O)(=O)N(CCN3CCOCC3)[C@@H](C(=O)NO)C(C)C)cc2)cc1","inchiKey":"YJNCFXPJICILOK-HHHXNRCGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SC-74020","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SC-74020"],"crossReferences":{"drugbank":["DB01630"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234905","canonicalSmiles":"Nc1ncc(C(=O)N(Cc2ccccc2)Cc2ccccc2)o1","inchiKey":"KIJXWOGFYAWTNC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234905","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08315"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236215","canonicalSmiles":"CSc1nc2ccccc2c(=O)n1-c1c(F)cccc1F","inchiKey":"BFNBJSXMXXQLAW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1236215","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08602"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL13254","canonicalSmiles":"CC[C@H](C(=O)Oc1c(OC)cc(C)cc1OC)N(CCOC)CCOC","inchiKey":"GKRFHHRXDUACIN-OAHLLOKOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ORG-24447","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ORG-24447"],"crossReferences":{"drugbank":["DB12312"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL134702","canonicalSmiles":"CCCC","inchiKey":"IJDNQMDRQITEOD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTANE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Butane","E-943","E943a","HC 600","Hc 600 (hydrocarbon)","INS NO.943","INS-943","N-butane","R 600","R 600 (alkane)"],"crossReferences":{"Wikipedia":["Butane"],"chEBI":["37808"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1354","canonicalSmiles":"CC(=O)[O-].[Na+]","inchiKey":"VMHLLURERBWHNL-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM ACETATE","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Acetic acid, sodium salt (1:1)","E-262(I)","E262","FEMA NO. 3024","INS NO.262(I)","INS-262(I)","NSC-77459","Sodium Acetate","Sodium acetate","Sodium acetate (3h2o)","Sodium acetate anhydrous","Sodium acetate hydrate","Sodium acetate trihydrate","Sodium acetate, anhydrous","Sodium acetate,anhydrous"],"crossReferences":{"DailyMed":["sodium%20acetate"],"DrugCentral":["4203"],"PubChem":["144209939"],"Wikipedia":["Sodium_acetate"],"drugbank":["DB09395"],"chEBI":["32954"]},"childChemblIds":["CHEMBL2107054"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1983 and is indicated for hyponatremia and hemorrhage and has 1 investigational indication."}
{"id":"CHEMBL1371937","canonicalSmiles":"CC(C)(CO)C(O)C(=O)NCCCO","inchiKey":"SNPLKNRPJHDVJA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PANTHENOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-759899","Panthenol","Panthenol, racemic"],"crossReferences":{"PubChem":["144212977","56320906"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1383","canonicalSmiles":"Nc1ncnc2c1ncn2[C@H]1CC[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O1","inchiKey":"OAKPWEUQDVLTCN-NKWVEPMBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DDATP","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2',3'-ddatp","2',3'-dideoxy-atp","Ddatp"],"crossReferences":{"drugbank":["DB02189"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1441570","canonicalSmiles":"Cc1cc(=O)oc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc12","inchiKey":"YUDPTGPSBJVHCN-YMILTQATSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1441570","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["49647071"],"drugbank":["DB13177"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1447","canonicalSmiles":"CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@@H](C)O)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1","inchiKey":"OJMMVQQUTAEWLP-KIDUDLJLSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LINCOMYCIN","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Lincolnensin","Lincomycin","U-10,149","U-10149"],"crossReferences":{"DailyMed":["lincomycin%20hydrochloride"],"PubChem":["29215234"],"Wikipedia":["Lincomycin"],"drugbank":["DB01627"],"chEBI":["6472"]},"childChemblIds":["CHEMBL3989551","CHEMBL1201097","CHEMBL4075711"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and has 3 approved and 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL148732","canonicalSmiles":"O=P(O)(O)C(c1ccccc1)P(=O)(O)O","inchiKey":"FRLTXWJJMCIUNT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL148732","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02908"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL149502","canonicalSmiles":"Cc1c(CC(N)=O)c2cc(OCCCP(=O)(O)O)ccc2n1Cc1ccccc1","inchiKey":"AQEYCNKFBRLUOT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL149502","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02504"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL153192","canonicalSmiles":"O=C(Nc1ccc(Cl)cc1)c1cc(Br)ccc1O","inchiKey":"QBSGXIBYUQJHMJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BROMOCHLOROSALICYLANILIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bromochlorosalicylanilide"],"crossReferences":{"drugbank":["DB13696"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL155886","canonicalSmiles":"CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O","inchiKey":"CRJGESKKUOMBCT-VQTJNVASSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CERAMIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ceramide"],"crossReferences":{"chEBI":["64913"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1611291","canonicalSmiles":"CCCCC/C(C=O)=C/c1ccccc1","inchiKey":"HMKKIXGYKWDQSV-KAMYIIQDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1611291","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["29217974"],"drugbank":["DB14175"],"chEBI":["32318"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1661","canonicalSmiles":"OC[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO","inchiKey":"VQHSOMBJVWLPSR-JVCRWLNRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LACTITOL","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Importal","Pizensy"],"synonyms":["BLI-400","D-lactitol","D-lactitol monohydrate","E-966","Finlac dc","INS NO.966","INS-966","Lactitol","Lactitol acm 50","Lactitol anhydrous","Lactitol hydrate","Lactitol monohydrate","Lactobiosit","Lactosit","Lactositol","Lacty (saccharide)","Milchen","Miruhen","NSC-231323","NSC-759131"],"crossReferences":{"DailyMed":["lactitol"],"PubChem":["144205950","170465917"],"drugbank":["DB12942"],"chEBI":["75323"]},"childChemblIds":["CHEMBL1200429"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for constipation and constipation disorder."}
{"id":"CHEMBL167691","canonicalSmiles":"CNC(=O)N(N(CCCl)S(C)(=O)=O)S(C)(=O)=O","inchiKey":"PVCULFYROUOVGJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LAROMUSTINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Cloretazine"],"synonyms":["101M","Laromustin","Laromustine","NSC-734246","Onrigin","VNP-40101M","VNP40101M"],"crossReferences":{"drugbank":["DB05817"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL1684","canonicalSmiles":"NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O","inchiKey":"HDWIHXWEUNVBIY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENDROFLUMETHIAZIDE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aprinox","Berkozide","Centyl","Naturetin","Naturetin-10","Naturetin-2.5","Naturetin-5","Neo-bendromax 2.5","Neo-bendromax 5","Neo-naclex","Urizide"],"synonyms":["Bendrofluazide","Bendroflumethiazide","Benzydroflumethiazide","NSC-758229"],"crossReferences":{"DailyMed":["bendroflumethiazide"],"PubChem":["124883448","144203916","170465156","26747201","56422088","855628"],"Wikipedia":["Bendroflumethiazide"],"drugbank":["DB00436"],"chEBI":["3013"]},"linkedTargets":{"rows":["ENSG00000070915"],"count":1},"linkedDiseases":{"rows":["EFO_0000319","EFO_0000537"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and is indicated for cardiovascular disease and hypertension."}
{"id":"CHEMBL169186","canonicalSmiles":"COc1cc2c(Nc3c(Cl)ccc4c3OCO4)ncnc2cc1OCCCN1CCCCC1","inchiKey":"QHIMVPIOWKYPSO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL169186","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07249"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL171246","canonicalSmiles":"CCC(=O)C(=O)O","inchiKey":"TYEYBOSBBBHJIV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-Oxo-Butyric Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Oxo-Butyric Acid","2-Oxobutanoate"],"crossReferences":{"Wikipedia":["Alpha-Ketobutyric_acid"],"drugbank":["DB04553"],"chEBI":["30831"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1743035","drugType":"Antibody","blackBoxWarning":false,"name":"LEBRIKIZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lebrikizumab","MILR-1444A","MILR1444A","PRO-301444","PRO-301444 RG-3637","PRO301444","RG-3637"],"linkedTargets":{"rows":["ENSG00000169194"],"count":1},"linkedDiseases":{"rows":["EFO_0000768","MONDO_0004979","EFO_0000341","EFO_0000274","MONDO_0004784"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL18136","canonicalSmiles":"N/C(=N\\O)N1CCC(CNC(=O)[C@@H]2CC[C@H]3CN(S(=O)(=O)Cc4ccccc4)CC(=O)N32)CC1","inchiKey":"DHTSUHWLPAEEQB-OALUTQOASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL18136","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02723"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL189","canonicalSmiles":"Cc1[nH]c(=O)c(C#N)cc1-c1ccncc1","inchiKey":"PZRHRDRVRGEVNW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MILRINONE","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Primacor"],"synonyms":["Milrila","Milrinone","NSC-760072","WIN 47,203-2","WIN-47203-2"],"crossReferences":{"DailyMed":["milrinone%20lactate"],"PubChem":["11111460","11111461","11114110","11532967","124880718","144205666","144214030","170465221","26757809","49681694","50104873","90341667"],"Wikipedia":["Milrinone"],"drugbank":["DB00235"],"chEBI":["50693"]},"childChemblIds":["CHEMBL1200977"],"linkedTargets":{"rows":["ENSG00000172572"],"count":1},"linkedDiseases":{"rows":["MONDO_0005149","EFO_0000713","EFO_0006834","EFO_0002687","EFO_0003144","HP_0004308","EFO_0005207","EFO_0009846","EFO_0000319","HP_0031273","HP_0030680","EFO_1000994"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and has 3 approved and 7 investigational indications."}
{"id":"CHEMBL1957038","canonicalSmiles":"Oc1ccc(C2=Cc3ccc(O)cc3OC2)cc1","inchiKey":"ZZUBHVMHNVYXRR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IDRONOXIL","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dehydroequol","Idronoxil","NV-06","Phenoxodiol"],"crossReferences":{"PubChem":["174006673"],"drugbank":["DB04915"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1987518","canonicalSmiles":"O=S(=O)(O)c1ccc2[nH]c(-c3ccccc3)nc2c1","inchiKey":"UVCJGUGAGLDPAA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENSULIZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ensulizole","Phenylbenzimidazole sulfonic acid"],"crossReferences":{"PubChem":["144205934","144208193","170465490","29218020"],"drugbank":["DB11115"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2062264","canonicalSmiles":"CNC[C@H](O)c1cccc(O)c1.O=C(O)C(O)C(O)C(=O)O","inchiKey":"NHKOTKKHHYKARN-FVGYRXGTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYLEPHRINE BITARTRATE","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1215","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Phenylephrine acid tartrate","Phenylephrine bitartrate","Phenylephrine hydrogen tartrate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1973."}
{"id":"CHEMBL2103796","canonicalSmiles":"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](OCc2ccccc2)[C@H](C)O1.Cl","inchiKey":"GPMIHHFZKBVWAZ-LMMKTYIZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BERUBICIN HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2110580","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Berubicin hcl","Berubicin hydrochloride","RTA 744","RTA-744","WP-744","WP744"],"linkedTargets":{"rows":["ENSG00000131747","ENSG00000077097"],"count":2},"linkedDiseases":{"rows":["MONDO_0100342","EFO_0000326","EFO_0000313","EFO_0000519"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2103872","canonicalSmiles":"Cn1c(N)c(NC(=O)NCCN)c[n+]1CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\\OC(C)(C)C(=O)[O-])c3nsc(N)n3)[C@H]2SC1","inchiKey":"JHFNIHVVXRKLEF-DCZLAGFPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFTOLOZANE","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CXA-101","CXA-101 FREE BASE","Ceftolozane","FR-264205"],"crossReferences":{"DailyMed":["ceftolozane%20sulfate"],"drugbank":["DB09050"]},"childChemblIds":["CHEMBL1213250"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for urinary tract infection and infection and has 6 investigational indications."}
{"id":"CHEMBL2105385","canonicalSmiles":"CCOC(=O)C1(c2ccccc2)CCN(CCC(O)c2ccccc2)CC1","inchiKey":"IPOPQVVNCFQFRK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENOPERIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dl-phenoperidine","Fenoperidine","IDS-NP-010","NIH 7591","NIH-7591","Phenoperidine","R 1406","R-1406"],"crossReferences":{"drugbank":["DB13605"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108197","drugType":"Unknown","blackBoxWarning":false,"name":"DEXTRIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dextrin"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2108233","drugType":"Unknown","blackBoxWarning":false,"name":"COCOA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cocoa"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108416","drugType":"Enzyme","blackBoxWarning":false,"name":"BRINOLASE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Brinase","Brinolase","CA-7","PROTEASE 1"],"description":"Enzyme drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2108659","drugType":"Unknown","blackBoxWarning":false,"name":"TRIGLYCERIDES, MEDIUM-CHAIN","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Medium chain triglycerides","Medium-chain triglycerides","Triglycerides, medium-chain"],"description":"Unknown drug with a maximum clinical trial phase of IV that was first approved in 2016 and has 1 investigational indication."}
{"id":"CHEMBL2108995","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBOMER 910","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Blephagel","Carbopol 910"],"synonyms":["Carbomer","Carbomer 910","Carbomer homopolymer","Carbopol","Carboxypolymethylene"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2218860","drugType":"Small molecule","blackBoxWarning":true,"name":"GADOBUTROL","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gadavist"],"synonyms":["BAY86-4875","Gadobutrol","Gadograf","Gadovist","Protovist","ZK 135079","ZK-135079"],"crossReferences":{"DailyMed":["gadobutrol"],"DrugCentral":["4179"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL22242","canonicalSmiles":"CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1OC","inchiKey":"GUJRSXAPGDDABA-NSHDSACASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REMOXIPRIDE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"],"classes":["Hematological toxicity"],"year":1993},"tradeNames":[],"synonyms":["A 33547","A-33547","FLA 731","FLA-731(-)","Remoxipride","Roxiam"],"crossReferences":{"PubChem":["11112836","11113786","144204485","170466425","26751966"],"Wikipedia":["Remoxipride"],"drugbank":["DB00409"]},"childChemblIds":["CHEMBL1899328","CHEMBL3989556"],"linkedTargets":{"rows":["ENSG00000149295"],"count":1},"linkedDiseases":{"rows":["EFO_0005407"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1990 and is indicated for psychosis. It was withdrawn in United Kingdom  in 1993 due to Hematological toxicity."}
{"id":"CHEMBL226495","canonicalSmiles":"OC[C@H]1O[C@H](Oc2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"BJRNKVDFDLYUGJ-ZIQFBCGOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL226495","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14109"],"chEBI":["29710"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2364621","canonicalSmiles":"CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O.O=S(=O)(O)CCO","inchiKey":"LYYVFHRFIJKPOV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PALBOCICLIB ISETHIONATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL189963","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PD 0332991-0054","PD-0332991-0054","PD-03329910054","PF-00080665-73","PF-0008066573","Palbociclib isethiolate","Palbociclib isethionate"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL242341","canonicalSmiles":"COc1ccc(-c2coc3cc(O)ccc3c2=O)cc1","inchiKey":"HKQYGTCOTHHOMP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FORMONONETIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["7-hydroxy-4'-methoxyisoflavone","Biochanin b","Flavosil","Formononetin","Formononetol","Myconate","Mycotech","NSC-93360","Neochanin"],"crossReferences":{"PubChem":["11113187","124882928","124882930","144212165","174006771","26749121","26753747","399180","46501240"],"Wikipedia":["Formononetin"],"drugbank":["DB15335"],"chEBI":["18088"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL256732","canonicalSmiles":"CCCCC(=O)N[C@H]1/C(=N/OC(=O)Nc2ccccc2)O[C@H](CO)[C@@H](O)[C@@H]1O","inchiKey":"NUNQIQQEEPOGDJ-JDOAOKHLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL256732","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08704"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL258805","canonicalSmiles":"COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2","inchiKey":"QNUKRWAIZMBVCU-WCIBSUBMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SU-9516","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SU-9516","Su-9516","Su9516"],"crossReferences":{"PubChem":["124891674","124891675","26753623","26753624","29215168","49674687","90341527"],"drugbank":["DB03428"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL267473","canonicalSmiles":"O=C(O)c1ccc(OCCn2ccnc2)cc1","inchiKey":"XQGZSYKGWHUSDH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DAZOXIBEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dazoxiben","UK-37248"],"crossReferences":{"PubChem":["50104198"],"Wikipedia":["Dazoxiben"],"drugbank":["DB03052"]},"childChemblIds":["CHEMBL537708"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL278315","canonicalSmiles":"COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\\C=C(/C)C(=O)NC(=CC1=O)C2=O","inchiKey":"QTQAWLPCGQOSGP-KSRBKZBZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GELDANAMYCIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Geldanamycin","NSC-122750"],"crossReferences":{"PubChem":["26756833","26756834"],"Wikipedia":["Geldanamycin"],"drugbank":["DB02424"],"chEBI":["5292"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL279260","canonicalSmiles":"C[C@H](Cc1c[nH]c2c(OCC(=O)O)cccc12)NC[C@H](O)c1cccc(Cl)c1","inchiKey":"FHEYFIGWYQJVDR-ACJLOTCBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RAFABEGRON","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AD-9677","Aj-9677","Rafabegron","TAK-677"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL283754","canonicalSmiles":"CCC(CC)(CC(=O)Nc1cccc(/C=C/c2nc(C3CCC3)cs2)c1)C(=O)O","inchiKey":"BZMKNPGKXJAIDV-VAWYXSNFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CINALUKAST","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cinalukast","RO 24-5913","RO-24-5913","RO-245913"],"crossReferences":{"PubChem":["144204742","170466361","26753192"],"drugbank":["DB00587"],"chEBI":["126598"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL304902","canonicalSmiles":"CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1","inchiKey":"KAAZGXDPUNNEFN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOTHIAPINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Clothiapine","Clotiapine","Entumin","HF-2159"],"crossReferences":{"PubChem":["144205332","170465938","26754613","29216068"],"Wikipedia":["Clotiapine"],"drugbank":["DB13256"]},"linkedTargets":{"rows":["ENSG00000135914","ENSG00000069696","ENSG00000149305","ENSG00000102468","ENSG00000186090","ENSG00000178084","ENSG00000186038","ENSG00000166736","ENSG00000147246"],"count":9},"linkedDiseases":{"rows":["EFO_0005407"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for psychosis."}
{"id":"CHEMBL3137304","canonicalSmiles":"Cc1ncccc1NC(=O)c1ccc2c(c1)CC[C@@H]1C[C@@](O)(C(F)(F)F)CC[C@@]21Cc1ccccc1","inchiKey":"QJJBNCHSWFGXML-KEKPKEOLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DAGROCORAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dagrocorat","PF-00251802","PF-0251802","PF-802"],"crossReferences":{"drugbank":["DB14676"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL316160","canonicalSmiles":"Cn1c(=O)c2[nH]c(Br)nc2n(C)c1=O","inchiKey":"SKTFQHRVFFOHTQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PAMABROM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pamabrom"],"crossReferences":{"PubChem":["144206112","170465479","50112818"],"drugbank":["DB14018"]},"childChemblIds":["CHEMBL2104825"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3183740","canonicalSmiles":"NC(=O)Cn1c(=O)cc(CCN2CCN(c3nccc4sccc34)CC2)c2ccc(F)cc21","inchiKey":"JDLYOFUDIKMYBL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRELANSERIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SL-650472","SL65.0472","Sl650472","Trelanserin"],"crossReferences":{"PubChem":["144210557"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL319139","canonicalSmiles":"CCOCn1c(Cc2cc(C)cc(C)c2)c(C(C)C)c(=O)[nH]c1=O","inchiKey":"NVGVZWUORYLPAL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL319139","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07820"],"chEBI":["42702"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL339996","canonicalSmiles":"CS(=O)(=O)Nc1ccc(C(=O)O)cc1","inchiKey":"SROHFTOYGFCJAF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-(Methylsulfonamido)Benzoic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-(Methylsulfonamido)Benzoic Acid","4-Methanesulfonylamino-Benzoic Acid"],"crossReferences":{"drugbank":["DB07114"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL34921","canonicalSmiles":"Cn1c(=O)[nH]c2c(=O)[nH]c(=O)[nH]c21","inchiKey":"XJEJWDFDVPDMAS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL34921","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03293"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544963","drugType":"Small molecule","blackBoxWarning":false,"name":"DS-3078A","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ds-3078a"],"linkedTargets":{"rows":["ENSG00000198793"],"count":1},"linkedDiseases":{"rows":["EFO_0000574"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545065","canonicalSmiles":"CN(C)C(C(=O)Nc1ccc2c(=O)[nH]ccc2c1)c1ccsc1","inchiKey":"VDYRZXYYQMMFJW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VEROSUDIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AR-12286","AR-12286 FREE BASE","Ar-12286","Verosudil"],"childChemblIds":["CHEMBL3545124"],"linkedTargets":{"rows":["ENSG00000134318","ENSG00000067900"],"count":2},"linkedDiseases":{"rows":["EFO_1001069","EFO_0000516"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545107","drugType":"Small molecule","blackBoxWarning":false,"name":"GRC-6211","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GRC6211","Grc-6211"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3545322","drugType":"Small molecule","blackBoxWarning":false,"name":"PANULISIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["P7170","Panulisib"],"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000139567","ENSG00000117461","ENSG00000198793"],"count":10},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3586436","canonicalSmiles":"Cc1cc(C)nc(N2C[C@H]3CN(C(=O)c4c(F)cccc4-n4nccn4)C[C@H]3C2)n1","inchiKey":"SQOCEMCKYDVLMM-IYBDPMFKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3586436","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14961"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3617964","canonicalSmiles":"Cc1c(-c2ccnn2C)cc(C(=O)NCc2ccc(S(C)(=O)=O)cn2)c(=O)n1-c1cccc(C(F)(F)F)c1","inchiKey":"QNQZWEGMKJBHEM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALVELESTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-9668","AZD9668","Alvelestat","Azd9668","MPH-966","MPH966","Mph966"],"crossReferences":{"drugbank":["DB11863"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL3833353","canonicalSmiles":"CC(=O)O.CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C)[C@@H](C)O","inchiKey":"DTPWZYSUQQHRKD-VIUAGAKSSA-N","drugType":"Protein","blackBoxWarning":true,"name":"PRAMLINTIDE ACETATE","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2103758","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Symlin","Symlinpen"],"synonyms":["AC0-137","AC0137","Pramlintide acetate","Pramlintide acetate anhydrous","Pramlintide acetate hydrate","Tripro-amylin acetate","Tripro-amylin acetate hydrate"],"linkedTargets":{"rows":["ENSG00000004948"],"count":1},"linkedDiseases":{"rows":["MONDO_0005147","MONDO_0005148","EFO_0001073"],"count":3},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989740","canonicalSmiles":"CCO.C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.Cl.Cl.O","inchiKey":"HALQELOKLVRWRI-VDBOFHIQSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DOXYCYCLINE HYCLATE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1433","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acticlate","Acticlate cap","Alodox","Atridox","Cyclodox","Demix 100","Demix 50","Doryx","Doryx mpc","Doxatet","Doxy","Doxy 100","Doxy 200","Doxy-Caps","Doxy-lemmon","Doxychel hyclate","Doxycycline hyclate","Doxylar","Lymepak","Nordox","Periostat","Ramysis","Vibra-tabs","Vibramycin","Vibramycin 50","Vibramycin Hyclate","Vibramycin acne pack","Vibramycin-d","Vibrox"],"synonyms":["Azudoxat","Clinofug","Diocimex","Doxicrisol","Doxycycline hyclate","Doxycycline hydrochloride hemiethanolate hemihydrate","Doxycyclini hyclas","Doxyprex","Duradoxal","Granudoxy","Mespafin","Monodoks","NSC-741421","Retens","Ronaxan","Spanor","Tetraclean","Tetradox","Unacil","Vibraveineuse","Vibravenos","Zadorin"],"crossReferences":{"DailyMed":["doxycycline%20hyclate"]},"linkedTargets":{"rows":["ENSG00000196611","ENSG00000137745","ENSG00000118113","ENSG00000137673"],"count":4},"linkedDiseases":{"rows":["EFO_1001388","EFO_1001896","EFO_1000760","EFO_0007205","EFO_0001365","EFO_0000649","EFO_1001898","EFO_1001466","Orphanet_774","EFO_0004607","EFO_1000961","EFO_0003894","EFO_0003955"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and is indicated for acne and has 9 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989904","canonicalSmiles":"CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OCC=Cc2cnc3ccccc3c2)C[C@@H](C)C(=O)[C@H](C)[C@H]2NC(=O)O[C@]12C","inchiKey":"PENDGIOBPJLVBT-AMXFZXBBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CETHROMYCIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-195773","ABBOTT-195773","ABT-773","Cethromycin"],"crossReferences":{"drugbank":["DB06419"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3989971","canonicalSmiles":"CC[C@H]1C[C@@H](C(=O)NCCNC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)C[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@H](CC3CCCCC3)C(=O)O)[C@H]2NC(C)=O)[C@@H]1O[C@@H]1O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]1O","inchiKey":"LYSYOXNOOPBOSC-NGSKMYNLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UPROLESELAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GMI-1271","GMI-1271 FREE ACID","Uproleselan"],"crossReferences":{"drugbank":["DB14829"]},"childChemblIds":["CHEMBL3989975"],"linkedTargets":{"rows":["ENSG00000007908"],"count":1},"linkedDiseases":{"rows":["MONDO_0100096","MONDO_0019457","EFO_0000222","EFO_0003907","EFO_0001378"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL399510","canonicalSmiles":"CCN(CC)CCNC(=O)c1cc(Br)c(N)cc1OC","inchiKey":"GIYAQDDTCWHPPL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BROMOPRIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bromopride","Movipride","NSC-758391"],"crossReferences":{"PubChem":["104171315","11112553","144204094","170466299","56463076"],"Wikipedia":["Bromopride"],"drugbank":["DB09018"]},"linkedTargets":{"rows":["ENSG00000149295"],"count":1},"linkedDiseases":{"rows":["EFO_0010282","EFO_0008533"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL406","canonicalSmiles":"CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1","inchiKey":"NDDAHWYSQHTHNT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDAPAMIDE","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cardide sr","Ethibide xl","Indapamide","Indaxa 2.5","Indipam xl","Lozol","Mapemid xl","Natrilix","Natrilix sr","Nindaxa 2.5","Opumide 2.5","Rawel xl","Tensaid xl","Varbim xl"],"synonyms":["Arifon","Bajaten","Damide","Flubest","Fludex","Fludin","Flupamid","Indaflex","Indamide","Indamol","Indapamide","Ipamix","KYD-041","Lorvas","NSC-757075","Natrix","Noranat","S-1520","SE-1520","Tandix","Tertensif","Veroxil"],"crossReferences":{"DailyMed":["indapamide"],"PubChem":["124883405","144204326","144206733","144213004","170465366","26747199","56422467","855885"],"Wikipedia":["Indapamide"],"drugbank":["DB00808"],"chEBI":["5893"]},"linkedTargets":{"rows":["ENSG00000070915"],"count":1},"linkedDiseases":{"rows":["EFO_0003840","EFO_0004253","EFO_0000373","EFO_0000319","MONDO_0005148","EFO_0000668","EFO_0000537"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1983 and has 4 approved and 2 investigational indications."}
{"id":"CHEMBL40733","canonicalSmiles":"N[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21","inchiKey":"SRPXSILJHWNFMK-ZBEGNZNMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DESMETHYLSERTRALINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Desmethylsertraline"],"crossReferences":{"drugbank":["DB14071"]},"childChemblIds":["CHEMBL1743864"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL418995","canonicalSmiles":"O=C(O)CCCCCCNC1c2ccccc2CCc2ccccc21","inchiKey":"ONNOFKFOZAJDHT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINEPTINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["France"," Thailand"],"classes":["Dermatological toxicity"," Misuse"],"year":1999},"tradeNames":[],"synonyms":["Amineptin","Amineptine"],"crossReferences":{"PubChem":["144206864"],"Wikipedia":["Amineptine"],"drugbank":["DB04836"],"chEBI":["32499"]},"childChemblIds":["CHEMBL1697712"],"linkedTargets":{"rows":["ENSG00000184845","ENSG00000149295"],"count":2},"linkedDiseases":{"rows":["EFO_0003761"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for unipolar depression. It was withdrawn in France and  Thailand initially in 1999 due to Dermatological toxicity and  Misuse."}
{"id":"CHEMBL4297275","canonicalSmiles":"Nc1nc(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1Cl","inchiKey":"NGGRGTWYSXYVDK-RRKCRQDMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYTOCHLOR","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5-cldc","Cytochlor","NSC-371331"],"crossReferences":{"drugbank":["DB12383"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297309","canonicalSmiles":"CC(C)CCNc1ncccc1C(=O)N1CCN(Cc2ccccc2)CC1.O=P(O)(O)O","inchiKey":"LWHMGALTTIYPJU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NSI-189 PHOSPHATE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL4302505","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nsi-189 phosphate"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297382","canonicalSmiles":"CCC(C)(C)C(=O)C(=O)N1CCC[C@H]1C(=O)O","inchiKey":"FOPALECPEUVCTL-QMMMGPOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GPI-1485","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GPI 1485","Gpi 1485","Gpi-1485"],"crossReferences":{"drugbank":["DB05814"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297564","drugType":"Unknown","blackBoxWarning":false,"name":"COBITOLIMOD","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cobitolimod"],"linkedTargets":{"rows":["ENSG00000239732"],"count":1},"linkedDiseases":{"rows":["EFO_0000729"],"count":1},"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297658","canonicalSmiles":"O=C(O)[C@@H]1CCCN1.OC[C@H]1O[C@@H](c2ccc(F)c(Cc3cc4ccccc4s3)c2)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"TUVGWWULBZIUBS-FVYIYGEMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IPRAGLIFLOZIN L-PROLINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ipragliflozin l-proline"],"linkedTargets":{"rows":["ENSG00000140675"],"count":1},"linkedDiseases":{"rows":["MONDO_0005148"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297761","drugType":"Protein","blackBoxWarning":false,"name":"GLEPAGLUTIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Glepaglutide","ZP-1848","ZP1848","Zp1848"],"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297791","drugType":"Unknown","blackBoxWarning":false,"name":"MVT-5873","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HUMAB-5B1","MVT-5873","Mvt-5873"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297911","drugType":"Antibody","blackBoxWarning":false,"name":"SPESOLIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BI 655130","BI-655130","BI655130","Bi655130","Spesolimab"],"linkedTargets":{"rows":["ENSG00000115598","ENSG00000196083"],"count":2},"linkedDiseases":{"rows":["EFO_0000729","Orphanet_247353","EFO_1000710","EFO_0000676","EFO_0000274","Orphanet_163927","EFO_0000384"],"count":7},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL4298007","drugType":"Protein","blackBoxWarning":false,"name":"ONFEKAFUSP ALFA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fibromun","L19-tnf","L19tnf","Onfekafusp alfa"],"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4298122","drugType":"Unknown","blackBoxWarning":false,"name":"CHLOROTOXIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chlorotoxin","TM-601","TM601","Tm 601","Tm-601"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL441920","canonicalSmiles":"C[C@@H](O)[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](Cc2ccccc2)NC(=O)CN2CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(=O)O","inchiKey":"QVFLVLMYXXNJDT-CSBVGUNJSA-N","drugType":"Protein","blackBoxWarning":false,"name":"CHEMBL441920","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14554"]},"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL447627","canonicalSmiles":"O=C(O)CNC(=O)c1cccc(O)c1","inchiKey":"XDOFWFNMYJRHEW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-Hydroxyhippuric Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-Hydroxyhippuric Acid"],"crossReferences":{"drugbank":["DB07069"],"chEBI":["70824"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL451887","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1","inchiKey":"BLMPQMFVWMYDKT-NZTKNTHTSA-N","drugType":"Protein","blackBoxWarning":false,"name":"CARFILZOMIB","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kyprolis"],"synonyms":["Carfilzomib","NSC-758252","PR-171"],"crossReferences":{"DailyMed":["carfilzomib"],"PubChem":["124955654","144206630","170466878"],"drugbank":["DB08889"],"chEBI":["65347"]},"linkedTargets":{"rows":["ENSG00000100804"],"count":1},"linkedDiseases":{"rows":["EFO_1001469","EFO_0005952","EFO_0000565","EFO_0000096","EFO_0000183","EFO_1000785","EFO_0009441","MONDO_0013730","EFO_0000616","MONDO_0019465","EFO_0000220","EFO_0000403","EFO_1001875","EFO_0000222","MONDO_0008315","EFO_0000311","EFO_0006738","EFO_0000211","EFO_0000304","MONDO_0002120","MONDO_0001023","EFO_0000095","EFO_0006475","EFO_0000702","EFO_0000574","MONDO_0002367","EFO_1001051","EFO_0001378","MONDO_0018906","MONDO_0024880","Orphanet_314701"],"count":31},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and has 3 approved and 25 investigational indications."}
{"id":"CHEMBL4594304","canonicalSmiles":"Cn1cc(S(=O)(=O)[C@@](C)(F)C2CCN(C(=O)Nc3ccon3)CC2)c(C(F)F)n1","inchiKey":"NREKKBAMVWQRES-MRXNPFEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DANICAMTIV","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Danicamtiv","MYK-491","MYK491","Myk-491","SAR-440181","SAR440181"],"linkedTargets":{"rows":["ENSG00000197616","ENSG00000160808","ENSG00000111245","ENSG00000106631","ENSG00000078814","ENSG00000092054","ENSG00000198336"],"count":7},"linkedDiseases":{"rows":["EFO_0000407"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594446","canonicalSmiles":"O=C(c1cc(Cl)c(O)c(Cl)c1)N1CS(=O)(=O)c2ccccc21","inchiKey":"VOFLAIHEELWYGO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOTINURAD","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dotinurad","FYU-981","Fyu-981"],"linkedTargets":{"rows":["ENSG00000197891"],"count":1},"linkedDiseases":{"rows":["HP_0000083","EFO_0009104","EFO_0004274"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594603","drugType":"Unknown","blackBoxWarning":false,"name":"LONOCTOCOG ALFA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Afstyla","CSL-627","CSL627","Lonoctocog alfa","Rviii-singlechain"],"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4594608","drugType":"Antibody","blackBoxWarning":false,"name":"AXATILIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Axatilimab","SNDX-6352","Sndx-6352","UCB-6352","UCB6352"],"linkedTargets":{"rows":["ENSG00000182578"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0013730","EFO_0009709","EFO_0005221"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4650383","drugType":"Unknown","blackBoxWarning":false,"name":"BRII-198","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BRII-198","Brii-198","Romlusevimab"],"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4650499","drugType":"Unknown","blackBoxWarning":false,"name":"IACS-010759","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IACS-010759","IACS-10759","Iacs 010759","Iacs-010759","Oxidative phosphorylation inhibitor iacs-010759"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL475251","canonicalSmiles":"COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC","inchiKey":"NHHQJBCNYHBUSI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"R-406","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["R-406","R940406","Tamatinib"],"crossReferences":{"PubChem":["103904600","137275829","99460878"],"drugbank":["DB07159"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL480853","canonicalSmiles":"C=C1CC[C@H]2[C@@](C)(CCC[C@@]2(C)CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H]1CCC1=CCOC1=O","inchiKey":"YGCYRQKJYWQXHG-RDNQFMDVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEOANDROGRAPHOLIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-neoandrographolide","Neoandrographiside","Neoandrographolide"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL482708","canonicalSmiles":"CN(c1nccc(-c2cnc3ccccn23)n1)C1CCCCC1","inchiKey":"HYNNWLVWJXWXFO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL482708","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08023"],"chEBI":["78508"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL51085","canonicalSmiles":"O=c1c2ccccc2[se]n1-c1ccccc1","inchiKey":"DYEFUKCXAQOFHX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EBSELEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DR-3305","DR3305","Ebselen","NSC-639762","NSC-757883","SPI-1005"],"crossReferences":{"PubChem":["11111148","11111149","124880036","124880040","144203691","26751591","50100237","50104231","50104232","50123266","50123267","56373765","56422439","85231032","856002","90341336"],"Wikipedia":["Ebselen"],"drugbank":["DB12610"],"chEBI":["77543"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL515774","canonicalSmiles":"CCCCOc1nc(NCCN2CCOCC2)c2ncn(Cc3c(F)cccc3F)c2n1","inchiKey":"UGZWPZWADDDTRN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL515774","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07937"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL525610","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C","inchiKey":"OGBMKVWORPGQRR-UMXFMPSGSA-N","drugType":"Protein","blackBoxWarning":true,"name":"TERIPARATIDE","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bonsity","Forsteo","Forteo"],"synonyms":["(1-34)-human parathyroid hormone","1-34-human pth","Human parathyroid hormone 1-34","LY 333334","LY-333334","LY333334","Pth (1-34)","Teriparatide","Teriparatide rdna","Teriparatide recombinant human","ZT-034"],"crossReferences":{"DailyMed":["teriparatide"]},"linkedTargets":{"rows":["ENSG00000160801"],"count":1},"linkedDiseases":{"rows":["EFO_0003943","EFO_0000685","HP_0002901","EFO_0009451","HP_0003418","Orphanet_666","EFO_0003882","EFO_0003964","HP_0000938","EFO_0003931","EFO_0003854","EFO_1001378","EFO_0003957","EFO_0004616","MONDO_0005178","EFO_0007490"],"count":16},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and is indicated for osteoporosis and has 12 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL574431","canonicalSmiles":"O=C1OC(c2ccc(O)c(S(=O)(=O)O)c2)(c2ccc(O)c(S(=O)(=O)O)c2)c2c(Br)c(Br)c(Br)c(Br)c21","inchiKey":"OHTXTCNTQJFRIG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFOBROMOPHTHALEIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sulfobromophtalein","Sulfobromophthalein","Sulfobromophthalein free acid","Sulfobromphthalein"],"crossReferences":{"drugbank":["DB13215"],"chEBI":["63836"]},"childChemblIds":["CHEMBL453904"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL61593","canonicalSmiles":"NS(=O)(=O)c1cc2c(cc1Cl)NC(C1CC3C=CC1C3)NS2(=O)=O","inchiKey":"BOCUKUHCLICSIY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOTHIAZIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anhydron","Fluidil"],"synonyms":["35483","Cyclothiazide","NSC-758431"],"crossReferences":{"PubChem":["144203675","170465274","26751850","50104549","50104550","56424127","85230990"],"Wikipedia":["Cyclothiazide"],"drugbank":["DB00606"],"chEBI":["31448"]},"linkedTargets":{"rows":["ENSG00000070915"],"count":1},"linkedDiseases":{"rows":["EFO_0000319"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for cardiovascular disease."}
{"id":"CHEMBL90983","canonicalSmiles":"COc1ccc(C[C@H](C)[C@H](C)Cc2ccc(OC)c(OC)c2)cc1OC","inchiKey":"ORQFDHFZSMXRLM-IYBDPMFKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TERAMEPROCOL","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EM 1421","EM-1421","Terameprocol"],"crossReferences":{"drugbank":["DB12226"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL92277","canonicalSmiles":"N=C(N)c1ccc2[nH]c(-c3cc(F)ccc3O)nc2c1","inchiKey":"JOGOACSSLJEREC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL92277","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02875"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
